PT-141, also known as Bremelanotide, is a synthetic cyclic research peptide derived from the melanocortin peptide family and structurally related to alpha-melanocyte-stimulating hormone (α-MSH). Unlike compounds primarily investigated through peripheral vascular mechanisms, PT-141 has become widely studied in laboratory research involving central melanocortin receptor signaling, neuroendocrine communication, and neurological pathways associated with reproductive biology.

PT-141 research has explored its activity at several melanocortin receptor subtypes, particularly MC3R and MC4R. Researchers have investigated these receptor systems to better understand the signaling mechanisms associated with melanocortin activity within the central nervous system.

Another significant area of PT-141 research involves the broader melanocortin system and its relationship with neuroendocrine signaling. Laboratory studies have examined receptor-mediated responses, neurological communication, and the biological mechanisms through which melanocortin pathways participate in physiological regulation.

PT-141 has a molecular weight of approximately 1,025.2 g/mol and is synthetically produced for controlled research applications. It is typically supplied as a white, lyophilized powder for laboratory investigation involving melanocortin receptor activity, neuroendocrine signaling, and related biological pathways.